Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holodniy

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
The AIDS Reader|September 1, 2000
HIV resistance testing--has it come of age?M Holodniy
Clinics in Laboratory Medicine|June 1, 1994
Clinical application of reverse transcription-polymerase chain reaction for HIV infectionM Holodniy
Methods in Molecular Medicine|February 23, 2011
Effects of collection, processing, and storage on RNA detection and quantificationM Holodniy
AIDS Patient Care and Stds|October 7, 2004
Phenotypic and genotypic testing in clinical practiceM Holodniy
AIDS Clinical Review|January 1, 1995
HIV viral load quantification, HIV resistance, and antiretroviral therapyD A Katzenstein, M Holodniy
AIDS Clinical Review|January 1, 1992
Quantitative virological measures of antiretroviral therapyD A Katzenstein, M Holodniy
Teratology|August 10, 2000
Assessment of developmental toxicity of antiretroviral drugs using a rat whole embryo culture systemM Fujinaga, M Schulte, M Holodniy
Pharmacoeconomics|November 11, 1999
Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical CenterL Mole, K Ockrim, M Holodniy
Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2001
A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infectionL Mole, D Schmidgall, M Holodniy
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 16, 2011
HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistanceP Schirmer, M Winters, M Holodniy
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
The AIDS Reader|September 1, 2000
HIV resistance testing--has it come of age?M Holodniy
Clinics in Laboratory Medicine|June 1, 1994
Clinical application of reverse transcription-polymerase chain reaction for HIV infectionM Holodniy
Methods in Molecular Medicine|February 23, 2011
Effects of collection, processing, and storage on RNA detection and quantificationM Holodniy
AIDS Patient Care and Stds|October 7, 2004
Phenotypic and genotypic testing in clinical practiceM Holodniy
AIDS Clinical Review|January 1, 1995
HIV viral load quantification, HIV resistance, and antiretroviral therapyD A Katzenstein, M Holodniy
AIDS Clinical Review|January 1, 1992
Quantitative virological measures of antiretroviral therapyD A Katzenstein, M Holodniy
Teratology|August 10, 2000
Assessment of developmental toxicity of antiretroviral drugs using a rat whole embryo culture systemM Fujinaga, M Schulte, M Holodniy
Pharmacoeconomics|November 11, 1999
Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical CenterL Mole, K Ockrim, M Holodniy
Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2001
A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infectionL Mole, D Schmidgall, M Holodniy
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 16, 2011
HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistanceP Schirmer, M Winters, M Holodniy
Pageof 7